Overview
The Sponsor-Investigator submits an IND Application to FDA that includes the components listed here.
IND Submission Components
- IND Cover Letter
- IND Application Template external site (opens in a new window)
- FDA Form 1571 - IND Application external site (opens in a new window) (and FDA Form 1571 Instructions external site (opens in a new window) )
- FDA Form 1572 - Statement of the IND Investigator) external site (opens in a new window) (see sample Box 8 - Protocol Summary Template external site (opens in a new window) )
- FDA Form 3454 - Certification: Financial Interests and Arrangements of Clinical Investigators external site (opens in a new window)
- FDA Form 3455 - Investigator Financial Interest Disclosure external site (opens in a new window)
- FDA Form 3674 - IND Certification of Compliance external site (opens in a new window)
- IND Protocol Template external site (opens in a new window)
- If applicable, Letter of Authorization (LOA) external site (opens in a new window) for the right of reference to the information contained in an existing IND application.
IND Forms and Instructions
FDA Guidance
The following FDA documents provide an overview of the IND application process:
- Investigator-Initiated Investigational New Drug (IND) Applications external site (opens in a new window) , especially Regulatory and Administrative Components external site (opens in a new window)
- FAQs about the IND Application external site (opens in a new window)
- Content and Format of IND Applications external site (opens in a new window)
- Exploratory INDs (aka Phase 0) external site (opens in a new window)
For specific situations: